Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*
Structure of HBV polymerase 575 - 583 (HLA-A*02:01)
Logo for Infectious disease
Infectious disease

HBV polymerase 575 - 583 (HLA-A*02:01) FLLSLGIHL

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP11192_1

Description

FLLSLGIHL is a linear peptidic epitope (epitope ID16751) studied as part of Protein P from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

TechData

Sequence: FLLSLGIHL
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Species: Hepatitis B virus (HBV)
Allele: HLA-A*02:01
Application: Flow Cytometry
Indication: Infectious disease, Cancer
Purity: 95% HPLC-MS

Documents

Material data sheet Safety data sheet Storage and handling of peptides Probing of membranes with HRP
Skip product gallery

More HBV peptides and peptide pools

Tip
HBV control Peptide Pool (>95% HPLC)
HBV control Peptide Pool (>95% HPLC)
This peptide pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).

€215.00*
HBV core 117-125 (HLA-A*24:02)
HBV core 117-125 (HLA-A*24:02)
EYLVSFGVW is a linear peptidic epitope (epitope ID15061) studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV core 18-27 (HLA-A*02:01)
HBV core 18-27 (HLA-A*02:01)
FLPSDFFPSV is a linear peptidic epitope studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. HBV core peptide FLPSDFFPSV (HLA-A*02:01) f for stimulation of human HBV core-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele.

From €105.00*
Details
HBV core 18-27 (subtype ADR4) (HLA-A*02:01)
HBV core 18-27 (subtype ADR4) (HLA-A*02:01)
FLPSDFFPSI is a linear peptidic epitope (epitope ID16832) studied as part of External core antigen from Hepatitis B virus and Capsid protein from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays

From €105.00*
Details
HBV core 19-27 (HLA-B*35:01) (HLA-B*51:01)
HBV core 19-27 (HLA-B*35:01) (HLA-B*51:01)
LPSDFFPSV is a linear peptidic epitope (epitope ID38701) studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV core antigen 88-96 (HLA-A*11:01)
HBV core antigen 88-96 (HLA-A*11:01)
YVNVNMGLK is a linear peptidic epitope (epitope ID76370) studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV envelope 183-191 (HLA-A*02:01)
HBV envelope 183-191 (HLA-A*02:01)
FLLTRILTI is a linear peptidic epitope (epitope ID16755) studied as part of Large envelope protein from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays

From €105.00*
Details
HBV envelope 335-343 (HLA-A*02:01)
HBV envelope 335-343 (HLA-A*02:01)
Antigen Peptide HBV envelope 335-343 (HLA-A*02:01) GLSPTVWLSV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. WLSLLVPFV is a linear peptidic epitope (epitope ID72794) studied as part of Large envelope protein from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €105.00*
Details
HBV envelope 348-357 (HLA-A*02:01)
HBV envelope 348-357 (HLA-A*02:01)
Antigen Peptide HBV envelope 348-357 (HLA-A*02:01) GLSPTVWLSV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
Details
HBV HBsAg 190-197 (H-2 Kb)
HBV HBsAg 190-197 (H-2 Kb)
VWLSVIWM is a linear peptidic epitope (epitope ID71948) studied as part of Large envelope protein from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV HBsAg 371-378 (H2-Kb)
HBV HBsAg 371-378 (H2-Kb)
IVSPFIPL is a linear peptidic epitope (epitope ID29454) studied as part of Large envelope protein from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV polymerase 756-764 (HLA-A*24:02)
HBV polymerase 756-764 (HLA-A*24:02)
KYTSFPWLL is a linear peptidic epitope (epitope ID34616) studied as part of Protein P from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HBV Protein P Peptide Pool
HBV Protein P Peptide Pool
Peptide pool of 209 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein P (UniProt ID: Q9WRL0) of Hepatitis B virus (HBV). One unit allows the stimulation of 2,5 x 108 cells.

€316.90*
HBV_Polymerase_171
HBV_Polymerase_171
SPYSWEQEL is a linear peptidic epitope studied as part of Protein P from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays.

From €105.00*
Details
HBVcore14, (HBA31)
HBVcore14, (HBA31)
STLPETTVVRR is a linear peptidic epitope studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €133.20*
Details
This website uses cookies to ensure the best experience possible. More information...